Clinical Trial Update: Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy [NA]

View source ↗

Summary

A completed clinical trial comparing 19-gauge versus 21-gauge EBUS TBNA for evaluating thoracic lymphadenopathy, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enlarged Lymph Nodes

Snippet

Sponsor: HealthPartners Institute | Conditions: Enlarged Lymph Nodes (Excluding Infective) | NA | Status: COMPLETED | Results posted: 2023-03-21